Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?

Overview of attention for article published in Diabetology & Metabolic Syndrome, April 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 20,713 followers.

RT @SEDiabetes: Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2…

RT @SEDiabetes: Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2…

RT @SEDiabetes: Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2…

RT @SEDiabetes: Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.